Cell Biology of Immunity against Intracellular Bacteria

Coordinator: Joaquin M. Pellegrini

Scientific Objectives


Intracellular bacterial infections remain a major global health challenge, exacerbated by the rise of multi-drug resistance and the limited efficacy of current vaccines. The Cell Biology of Immunity against Intracellular Bacteria laboratory seeks to redefine antibacterial strategies by addressing a central question:

How can we harness immune cell processes to better control bacterial infections?

Our team investigates how fundamental cellular pathways -including autophagy, inflammasome signaling, and SLAMF receptor networks- shape innate and adaptive immune responses to intracellular pathogens. Using Salmonella as a primary model and integrating human patient samples with in vivo and in vitro systems, we combine advanced cytometry, microscopy, and proteomics to uncover mechanisms that can be translated into innovative therapeutic strategies and next-generation vaccines.

The CBIIB lab, launched in January 2026, welcomes applications from highly motivated researchers to be part of our team. Contact us!

Our Projects


Axis 1: Decoding human immune responses to intracellular bacterial infections

We are building a translational research network connecting Purpan Hospital in Toulouse with major clinical centers in Argentina, including the Maternal and Child Hospital of Salta and the Malbrán Institute. This collaboration enables access to well-characterized and complementary patient cohorts with longitudinal clinical follow-up, providing a strong foundation for integrated human immunology studies of salmonellosis.

By combining blood and mucosal samples with high-dimensional cytometry, transcriptomic, and proteomic approaches, we aim to identify immune cell subsets and regulatory pathways that correlate with disease outcome and protection. Particular emphasis is placed on understanding the contribution of specialized innate subsets, including plasmacytoid dendritic cells, within the broader immune landscape of human infection.

 

Axis 2: Immune cell-intrinsic circuits shaping antibacterial defense

We aim to dissect the cell-intrinsic signaling circuits that coordinate antibacterial immunity, with a particular focus on plasmacytoid dendritic cells as key regulatory nodes during infection. Although renowned for their role in antiviral responses due to their exceptional capacity to produce huge amounts of type I IFN, their contribution to defense against bacteria remains poorly understood. Using genetic mouse models, including constitutive pDC-deficient systems, together with complementary in vitro approaches, we investigate how autophagy, inflammasome activation, and SLAMF receptor networks integrate to control innate immune function. These studies aim to define molecular checkpoints that determine protective versus pathological immune responses.

Axis 3: Reprogramming immunity: toward next-generation antibacterial vaccination

In the context of rising antibiotic resistance, emerging pathogens, and persistent epidemics such as tuberculosis, malaria, and COVID-19, there is an urgent need for innovative, safe, and effective vaccines that can elicit robust cell-mediated immunity. Building on mechanistic insights from human studies and experimental models, we aim to develop innovative immunomodulatory strategies to enhance antibacterial protection. In particular, we explore next-generation vaccination platforms designed to target specific immune cell subsets and optimize protective responses against intracellular pathogens. Our objective is to translate fundamental discoveries into rationally engineered immune interventions.

Other information


Publications

2025

Morelli, María Paula; Martin, Candela; Pellegrini, Joaquín Miguel; Blanco, Federico; Bigi, Fabiana; Ciallella, Lorena; Musella, Rosa; Mieres, Adriana Rodriguez; de Casado, Graciela C; Palmero, Domingo Juan; García, Verónica Edith

Neutrophils from tuberculosis patients are polarized toward pro-inflammatory and anti-inflammatory phenotypes according to the disease severity Journal Article

In: J Immunol, vol. 214, no. 6, pp. 1173–1186, 2025, ISSN: 1550-6606.

Abstract | Links | BibTeX

Pellegrini, Joaquín Miguel; Keriel, Anne; Gorvel, Laurent; Hanniffy, Sean; Arce-Gorvel, Vilma; Bosilkovski, Mile; Solera, Javier; Méresse, Stéphane; Mémet, Sylvie; Gorvel, Jean-Pierre

SLAMF7 and SLAMF8 receptors shape human plasmacytoid dendritic cell responses to intracellular bacteria Journal Article

In: J Clin Invest, vol. 135, no. 8, 2025, ISSN: 1558-8238.

Abstract | Links | BibTeX

Niu, Hua; Herb, Marc; Pellegrini, Joaquin Miguel

Editorial: The role of autophagy in infectious diseases, volume II Miscellaneous

2025, ISSN: 2235-2988.

Links | BibTeX

Pellegrini, Joaquin M; González-Espinoza, Gabriela; Shayan, Raheleh R; Hysenaj, Lisiena; Rouma, Thomas; Arce-Gorvel, Vilma; Lelouard, Hugues; Popoff, Dimitri; Zhao, Yun; Hanniffy, Sean; Castillo-Zeledón, Amanda; Loperena-Barber, Maite; Celis-Gutierrez, Javier; Mionnet, Cyrille; Bosilkovski, Mile; Solera, Javier; Muraille, Eric; Barquero-Calvo, Elías; Moreno, Edgardo; Conde-Álvarez, Raquel; Moriyón, Ignacio; Gorvel, Jean-Pierre; Mémet, Sylvie

Brucella abortus impairs T lymphocyte responsiveness by mobilizing IL-1RA-secreting omental neutrophils Journal Article

In: Nat Commun, vol. 16, no. 1, pp. 862, 2025, ISSN: 2041-1723.

Abstract | Links | BibTeX

2024

Loperena-Barber, Maite; Elizalde-Bielsa, Aitor; Salvador-Bescós, Miriam; Ruiz-Rodríguez, Paula; Pellegrini, Joaquin Miguel; Renau-Mínguez, Chantal; Lancaster, Rebecca; Zúñiga-Ripa, Amaia; Iriarte, Maite; Bengoechea, Jose A; Coscollá, Mireia; Gorvel, Jean-Pierre; Moriyón, Ignacio; Conde-Álvarez, Raquel

Journal Article

In: Infect Genet Evol, vol. 123, pp. 105625, 2024, ISSN: 1567-7257.

Abstract | Links | BibTeX

2023

Tateosian, Nancy Liliana; Morelli, María Paula; Pellegrini, Joaquín Miguel; García, Verónica Edith

Beyond the Clinic: The Activation of Diverse Cellular and Humoral Factors Shapes the Immunological Status of Patients with Active Tuberculosis Journal Article

In: Int J Mol Sci, vol. 24, no. 5, 2023, ISSN: 1422-0067.

Abstract | Links | BibTeX

Pellegrini, Joaquin Miguel; Morelli, María Paula; Colombo, María Isabel; García, Verónica Edith

Editorial: Beneficial and detrimental host cellular responses against infection Miscellaneous

2023, ISSN: 2235-2988.

Links | BibTeX

2022

Pellegrini, Joaquin Miguel; Gorvel, Jean-Pierre; Mémet, Sylvie

Immunosuppressive Mechanisms in Brucellosis in Light of Chronic Bacterial Diseases Journal Article

In: Microorganisms, vol. 10, no. 7, 2022, ISSN: 2076-2607.

Abstract | Links | BibTeX

Amiano, Nicolás O; Pellegrini, Joaquín M; Morelli, María P; Martinena, Camila; Rolandelli, Agustín; Castello, Florencia A; Casco, Nicolás; Ciallella, Lorena M; de Casado, Graciela C; Armitano, Rita; Stupka, Juan; Gallego, Claudio; Palmero, Domingo J; García, Verónica E; Tateosian, Nancy L

Circulating Monocyte-Like Myeloid Derived Suppressor Cells and CD16 Positive Monocytes Correlate With Immunological Responsiveness of Tuberculosis Patients Journal Article

In: Front Cell Infect Microbiol, vol. 12, pp. 841741, 2022, ISSN: 2235-2988.

Abstract | Links | BibTeX

2021

Pellegrini, Joaquín Miguel; Sabbione, Florencia; Morelli, María Paula; Tateosian, Nancy Liliana; Castello, Florencia Andrea; Amiano, Nicolás Oscar; Palmero, Domingo; Levi, Alberto; Ciallella, Lorena; Colombo, María Isabel; Trevani, Analía Silvina; García, Verónica Edith

Neutrophil autophagy during human active tuberculosis is modulated by SLAMF1 Journal Article

In: Autophagy, vol. 17, no. 9, pp. 2629–2638, 2021, ISSN: 1554-8635.

Abstract | Links | BibTeX

Pellegrini, Joaquín Miguel; Martin, Candela; Morelli, María Paula; Schander, Julieta Aylen; Tateosian, Nancy Liliana; Amiano, Nicolás Oscar; Rolandelli, Agustín; Palmero, Domingo Juan; Levi, Alberto; Ciallella, Lorena; Colombo, María Isabel; García, Verónica Edith

PGE2 displays immunosuppressive effects during human active tuberculosis Journal Article

In: Sci Rep, vol. 11, no. 1, pp. 13559, 2021, ISSN: 2045-2322.

Abstract | Links | BibTeX

Pellegrini, Joaquin Miguel; Tateosian, Nancy Liliana; Morelli, María Paula; García, Verónica Edith

Shedding Light on Autophagy During Human Tuberculosis. A Long Way to Go Journal Article

In: Front Cell Infect Microbiol, vol. 11, pp. 820095, 2021, ISSN: 2235-2988.

Abstract | Links | BibTeX

2017

Tateosian, Nancy Liliana; Pellegrini, Joaquín Miguel; Amiano, Nicolás Oscar; Rolandelli, Agustín; Casco, Nicolás; Palmero, Domingo Juan; Colombo, María Isabel; García, Verónica Edith

IL17A augments autophagy in Mycobacterium tuberculosis-infected monocytes from patients with active tuberculosis in association with the severity of the disease Journal Article

In: Autophagy, vol. 13, no. 7, pp. 1191–1204, 2017, ISSN: 1554-8635.

Abstract | Links | BibTeX

Societal impact

Chronic bacterial infections remain a major public health challenge, causing significant morbidity, mortality, and economic burden worldwide. Current treatments still rely heavily on antibiotics, which are increasingly compromised by antimicrobial resistance. In parallel, effective vaccines against many intracellular bacteria are still lacking.

Our research addresses this urgent need by identifying new immune mechanisms and therapeutic targets to strengthen host protection against intracellular pathogens. We aim to contribute to the rational design of next-generation vaccines and to the development of host-directed therapies that enhance protective immunity while reducing antibiotic dependence.

By using Salmonella as a model intracellular pathogen, we study immune pathways that can be therapeutically leveraged and extended to other medically relevant bacteria. Because salmonellosis and brucellosis are zoonotic diseases, our work is aligned with the One Health framework, integrating human and animal health perspectives to improve prevention strategies and reduce disease transmission across species.

Alumni
Collaborations
Rita Vos (IMEC, Leuven, Belgium)
Margarita del Val (CBM Severo Ochoa, CSIC, Madrid, Spain).
Alberto Hernandez (CSIC, Madrid, Spain).
Verónica Garcia (IQUIBICEN, Buenos Aires, Argentina).
Magdalena Maresca (Hospital Público Materno Infantil de Salta, Salta, Argentina).
María Rosa Viñas (Institute of Infectious Diseases ‘Carlos G. Malbrán,’ Buenos Aires, Argentina).
Jay Hinton (Universitiy of Liverpool, Liverpool, UK)
Marc Dalod and Elena Tomasello (CIML, Marseille, France).
Hugues Lelouard (CIML, Marseille, France).
Rafael Arguello (CIML, Marseille, France).
Guillaume Martin-Blondel (Infinity, Toulouse, France).
Beatrice Pignolet (Infinity, Toulouse, France).

 

Partenaires équipe J. Pellegrini